Forbes -
15 May 2014 19:48
We believe that the impressive trial results could help improve market sentiment in favor of Medtronic?s pacemaker products and drive sales going forward. We also expect new products such as the Advisa MRI-safe pacemaker to help the company get back to positive sales growth in the near to medium term.
Share this Article
Comment on this Article
Please to comment